Progress has been made, but there’s still a long road ahead.
Eli Lilly added additional affordability options for patients with diabetes who use certain insulin products.
Antipsychotics were not associated with an increased risk of morbidity and mortality in patients with schizophrenia in a new study.
Optimism is strong around the pharmacy industry as we head into a new decade, and many believe that 2020 is going to be a pivotal year for the industry.
Patients with diabetes now have access to more technology than ever before to help them manage the chronic disease, but the devices can be complicated for patients to use.
A study evaluated the ability of untrained individuals to use different forms of naloxone administration.
Here are the top drugs expected to be approved this year.
NACDS says DIR fees, other policies need to change.
Viaskin Peanut (DBV Technologies) achieved durable, long-term clinical benefit in peanut-allergic children.
Individuals with a history of heart disease may be at an increased risk of developing kidney failure.